These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 31538883)
21. Inhibitory Effects of the Polyphenols from the Root of Liang Y; Ban Y; Liu L; Li Y Molecules; 2024 Mar; 29(5):. PubMed ID: 38474695 [TBL] [Abstract][Full Text] [Related]
22. The extract of leaves of Acer truncatum Bunge: A natural inhibitor of fatty acid synthase with antitumor activity. Zhao WH; Zhang JF; Zhe-Wang ; Zhang YX; Tian WX J Enzyme Inhib Med Chem; 2006 Oct; 21(5):589-96. PubMed ID: 17194032 [TBL] [Abstract][Full Text] [Related]
23. Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors. Zhou G; Ting PC; Wishart G; Zorn N; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J Bioorg Med Chem Lett; 2014 Apr; 24(7):1790-4. PubMed ID: 24618302 [TBL] [Abstract][Full Text] [Related]
24. Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN). Martin MW; Lancia DR; Li H; Schiller SER; Toms AV; Wang Z; Bair KW; Castro J; Fessler S; Gotur D; Hubbs SE; Kauffman GS; Kershaw M; Luke GP; McKinnon C; Yao L; Lu W; Millan DS Bioorg Med Chem Lett; 2019 Apr; 29(8):1001-1006. PubMed ID: 30803804 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of tannic acid on fatty acid synthase and 3T3-L1 preadipocyte. Fan H; Wu D; Tian W; Ma X Biochim Biophys Acta; 2013 Jul; 1831(7):1260-6. PubMed ID: 24046866 [TBL] [Abstract][Full Text] [Related]
26. Development of a Medium-Throughput Targeted LCMS Assay to Detect Endogenous Cellular Levels of Malonyl-CoA to Screen Fatty Acid Synthase Inhibitors. Hopcroft PJ; Fisher DI J Biomol Screen; 2016 Feb; 21(2):111-6. PubMed ID: 26586251 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological activities, and docking studies of d-pantolactone derivatives as novel FAS inhibitors. Fang H; He J; Ran T; Chen H; Jin W; Tang B; Hong Z; Fang M Bioorg Med Chem; 2019 Oct; 27(20):115069. PubMed ID: 31492533 [TBL] [Abstract][Full Text] [Related]
29. Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the beta-ketoacyl reductase reaction. Vázquez MJ; Leavens W; Liu R; Rodríguez B; Read M; Richards S; Winegar D; Domínguez JM FEBS J; 2008 Apr; 275(7):1556-1567. PubMed ID: 18312417 [TBL] [Abstract][Full Text] [Related]
30. Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones. Kravchenko DV; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV Eur J Med Chem; 2005 Dec; 40(12):1377-83. PubMed ID: 16169127 [TBL] [Abstract][Full Text] [Related]
31. NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition. Cui Y; Xing P; Wang Y; Liu M; Qiu L; Ying G; Li B Oncotarget; 2017 May; 8(20):32576-32585. PubMed ID: 28427229 [TBL] [Abstract][Full Text] [Related]
32. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? Lupu R; Menendez JA Endocrinology; 2006 Sep; 147(9):4056-66. PubMed ID: 16809439 [TBL] [Abstract][Full Text] [Related]
33. Discovery of novel fatty acid synthase (FAS) inhibitors based on the structure of ketoaceyl synthase (KS) domain. Zeng XF; Li WW; Fan HJ; Wang XY; Ji P; Wang ZR; Ma S; Li LL; Ma XF; Yang SY Bioorg Med Chem Lett; 2011 Aug; 21(16):4742-4. PubMed ID: 21752639 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase. Garbaccio RM; Huang S; Tasber ES; Fraley ME; Yan Y; Munshi S; Ikuta M; Kuo L; Kreatsoulas C; Stirdivant S; Drakas B; Rickert K; Walsh ES; Hamilton KA; Buser CA; Hardwick J; Mao X; Beck SC; Abrams MT; Tao W; Lobell R; Sepp-Lorenzino L; Hartman GD Bioorg Med Chem Lett; 2007 Nov; 17(22):6280-5. PubMed ID: 17900896 [TBL] [Abstract][Full Text] [Related]
35. Presence of fatty acid synthase inhibitors in the rhizome of Alpinia officinarum hance. Li BH; Tian WX J Enzyme Inhib Med Chem; 2003 Aug; 18(4):349-56. PubMed ID: 14567550 [TBL] [Abstract][Full Text] [Related]
36. The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase. Wang X; Song KS; Guo QX; Tian WX Biochem Pharmacol; 2003 Nov; 66(10):2039-47. PubMed ID: 14599562 [TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. Oh J; Hwang IH; Hong CE; Lyu SY; Na M J Enzyme Inhib Med Chem; 2013 Jun; 28(3):565-8. PubMed ID: 22380770 [TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer. Crous-Masó J; Palomeras S; Relat J; Camó C; Martínez-Garza Ú; Planas M; Feliu L; Puig T Molecules; 2018 May; 23(5):. PubMed ID: 29751678 [TBL] [Abstract][Full Text] [Related]
40. Potent inhibition of fatty acid synthase by parasitic loranthus [Taxillus chinensis (dc.) danser] and its constituent avicularin. Wang Y; Zhang SY; Ma XF; Tian WX J Enzyme Inhib Med Chem; 2006 Feb; 21(1):87-93. PubMed ID: 16570511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]